If pancreatitis is suspected, Wegovy should be discontinued and appropriate diagnostic tests performed urgently Gallbladder problems : Rapid weight loss increases risk of gallstone formation, with cholelithiasis reported in approximately 1.6% of Wegovy users Intestinal obstruction/ileus : Cases have been reported in post-marketing surveillance, particularly in patients with pre-existing GI conditions Management strategies recommended by healthcare professionals include: Eating smaller, more frequent meals rather than large portions Avoiding high-fat, spicy, or heavily processed foods Staying well-hydrated, particularly if experiencing diarrhoea or vomiting, to prevent dehydration and potential acute kidney injury Not lying down immediately after eating to minimise reflux Ensuring adequate fibre intake to prevent constipation Taking the medication on the same day each week to maintain steady levels Most GI side effects improve over time as the body adjusts to the medication, typically becoming less troublesome after 4-8 weeks at each dose level

Record lot identifiers in laboratory notebooks before reconstitution
It belongs to a class of molecules called growth hormone secretagogues (GHSs): compounds that provoke the release of growth hormone (GH) without being growth hormone themselves
10.4161/epi.4.6.9767 Epigenetics 75 MaedaT.WakasawaT.FunabashiM.FukushiA.FujitaM.MotojimaK.et al (2008)
6 Plan Maintenance Long-term care may involve continued medication, another dose or route, a different drug, lifestyle treatment, or referral
While the compound accumulates over time and produces effects regardless of timing, the pre-workout dose may provide subjective benefits during the session